Application of 3D biomimetic models in drug delivery and regenerative medicine

Current Pharmaceutical Design

Volumn 21, Issue 12, 2015, Pages 1618-1626

  Xu, Yufan ^a   Wang, Xiaohong ^a,b  

^a TSINGHUA UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

3D models; Biomaterials; Drug delivery; Nanotechnology; Regenerative medicine

Indexed keywords

ARTICLE; BIOMIMETICS; CANCER THERAPY; CELL INTERACTION; DRUG DELIVERY SYSTEM; HYDROGEL; NANOTECHNOLOGY; PHYSICAL MODEL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; THREE DIMENSIONAL PRINTING; TISSUE ENGINEERING; ANIMAL; CHEMISTRY; HUMAN; PROCEDURES; THREE DIMENSIONAL IMAGING;

BIOMATERIAL;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOMIMETICS; DRUG DELIVERY SYSTEMS; HUMANS; IMAGING, THREE-DIMENSIONAL; NANOTECHNOLOGY; PRINTING, THREE-DIMENSIONAL; REGENERATIVE MEDICINE; TISSUE ENGINEERING;

EID: 84930886019     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612821666150115154059     Document Type: Article

References (159)

1. Drews J. Drug discovery: a historical perspective. Science 2000; 287: 1960-4.
2. Goth A. Medical Pharmacology 7th ed. St Louis: CB Mosby Co, 1974.
3. Hamidi M, Azadi A, Rafiei P, et al. A pharmacokinetic overview of nanotechnology-based drug delivery systems: an ADMEoriented approach. Crit Rev Ther Drug Carrier Syst 2013; 30: 435-67.
4. Penrod NM, Cowper-Sal-lari R, Moore JH. Systems genetics for drug target discovery. Trends Pharmacol Sci 2011; 32: 623-30.
5. Houk BE, Bello CL, Poland B, Rosen LS, Demetri GD, Motzer RJ. Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis. Cancer Chemother Pharmacol 2010; 66: 357-71.
6. Murua A, Portero A, Orive G, Hernández RM, de Castro M, Pedraz JL. Cell microencapsulation technology: towards clinical application. J Control Release 2008; 132: 76-83.
7. Depan D, Shah J, Misra RDK. Controlled release of drug from folate-decorated and graphene mediated drug delivery system: synthesis, loading efficiency, and drug release response. Mater SciEng C 2011; 31: 1305-12.
8. González JE, Maher MP. Cellular fluorescent indicators and voltage/ion probe reader (VIPR) tools for ion channel and receptor drug discovery. Receptors Channels 2002; 8: 283-95.
9. Lappano R, Maggiolini M. G protein-coupled receptors: novel targets for drug discovery in cancer. Nat Rev Drug Discov 2011; 10: 47-60.
10. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000; 103: 211-25.
11. Kavvoura FK, Pappa M, Evangelou E, Ntzani EE. The genetic architecture of type 2 diabetes pharmacotherapy: the emerging genomic evidence. Curr Pharm Des 2014; 20: 3610-9.
12. Shimizu T, Sekine H, Yamato M, Okano T. Cell sheet-based myocardial tissue engineering: new hope for damaged heart rescue. Curr Pharm Des 2009; 15:2807-14.
13. Schreiber SL. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science 2000; 287: 1964-9.
14. Mimeault M, Hauke R, Batra SK. Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther 2007; 82: 252-64.
15. Phinney DG, Isakova I. Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. Curr Pharm Des 2005; 11: 1255-65.
16. Planat-Benard V, Silvestre JS, Cousin B, et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 2004;109:656-63.
17. Simper D, Stalboerger PG, Panetta CJ, et al. Smooth muscle progenitor cells in human blood. Circulation 2002; 106: 1199-204.
18. Wüst S, Müller R, Hofmann S. Controlled positioning of cells in biomaterials-approaches towards 3D tissue printing. J Funct Biomater 2011; 2: 119-54.
19. Pollard HB, Srivastava M, Eidelman O, et al. Protein microarray platforms for clinical proteomics. Proteomics ClinAppl 2007; 1: 934-52.
20. Bucht A, Larsson P, Weisbrot L, et al. Expression of interferongamma (IFN-gamma), IL-10, IL-12 and transforming growth factor-beta (TGF-beta) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA). Clin Exp Immunol 1996; 103: 357-67.
21. Demeule M, Régina A, Ché C, et al. Identification and design of peptides as a new drug delivery system for the brain. J Pharmacol ExpTher 2008; 324: 1064-72.
22. Simons M, Bonow RO, Chronos NA, et al. Clinical trials in coronary angiogenesis: issues, problems, consensus: an expert panel summary. Circulation 2000; 102: E73-86.
23. Epstein SE, Fuchs S, Zhou YF, et al. Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards. Cardiovasc Res 2001; 49: 532-42.
24. Babensee JE, McIntire LV, Mikos AG. Growth factor delivery for tissue engineering. Pharm Res 2000; 17: 497-504.
25. Hunt JA. Regenerative medicine: materials in a cellular world. Nat Mater 2008; 7: 617-8.
26. Wang X, Tuomi J, Mäkitie AA, et al. The integrations of biomaterials and rapid prototyping techniques for intelligent manufacturing of complex organs. In: Pignatello R, editor. Advances in Biomaterials Science and Biomedical Applications. Croatia: InTech, 2013, p.437-63.
27. Dash M, Chiellini F, Ottenbrite RM, et al. Chitosan-a versatile semi-synthetic polymer in biomedical applications. Prog Polym Sci 2011; 36: 981-1014.
28. Wang X, Sui S, Yan Y, et al. Design and fabrication of PLGA sandwiched cell/fibrin constructs for complex organ regeneration. J Bioact Compat Polym 2010; 25: 229-40.
29. Martin I, Wendt D, Heberer M. The role of bioreactors in tissue engineering. Trends Biotechnol 2004; 22: 80-6.
30. Lee KH, Shin SJ, Park Y, et al. Synthesis of cell-laden alginate hollow fibers using microfluidic chips and microvascularized tissue-engineering applications. Small 2009; 5: 1264-8.
31. Croisier F, Jérôme C. Chitosan-based biomaterials for tissue engineering. Eur Polym J 2013; 49: 780-92.
32. Prabhakaran MP, Ghasemi-Mobarakeh L, Ramakrishna S. Electrospun composite nanofibers for tissue regeneration. J Nanosci Nanotechnol 2011; 11: 3039-57.
33. Tuzlakoglu K, Alves CM, Mano JF, et al. Production and characterization of chitosan fibers and 3-D fiber mesh scaffolds for tissue engineering applications. Macromol Biosci 2004; 4: 811-9.
34. Chen Q, Liang S, Thouas GA. Elastomeric biomaterials for tissue engineering. Prog Polym Sci 2013; 38: 584-671.
35. Drury JL, Mooney DJ. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 2003; 24: 4337-51.
36. Wang X, Ma J, Feng Q, et al. In vivo evaluation of S-chitosan enhanced calcium phosphate cements. J Bioact Compat Polym 2003; 18: 259-71.
37. Wang X, Zhu Y, Feng Q, et al. Responses of osteo-and fibroblast cells to phosphorylated chitin. J Bioact Compat Polym 2003; 18: 135-46.
38. Wang X, Feng Q, Cui F, et al. The effects of S-chitosan on the physical properties of calcium phosphate cements. J Bioact Compat Polym 2003; 18: 45-57.
39. Wang X, Li D, Wang W, et al. Crosslinked collagen/chitosan matrix for artificial livers. Biomaterials 2003, 24: 3213-20.
40. Wang X, Ma J, Feng Q, et al. Skeletal repair in rabbits with calcium phosphate cements incorporated phosphorylated chitin. Biomaterials 2002; 23: 4591-600.
41. Wang X, Ma J, Wang Y, et al. Bone repair in radii and tibias of rabbits with phosphorylated chitosan reinforced calcium phosphate cements. Biomaterials 2002; 23: 4167-76.
42. Wang X, Ma J, Wang Y, et al. Structural characterization of phosphorylated chitosan and their applications as effective additives of calcium phosphate cements. Biomaterials 2001; 22: 2247-55.
43. Zhu Y, Wang X, Cui F, et al. In vitro cytocompatibility and osteoinduction of phosphorylated chitosan with osteoblasts. J Bioact Compat Polym 2003; 18: 375-90.
44. Wang X, Cui F, Feng Q, et al. Preparation and characterization of collagen/chitosan matrices as potential biomaterials. J Bioact Compat Polym 2003; 18: 453-67.
45. Wang W, Wang X, Feng Q, et al. Sodium alginate crosslinked with EDC as a scaffold for hepatic tissue engineering. J Bioact Compat Polym 2003; 18: 249-57.
46. Yu X, Bichtelen A, Wang X, et al. Collagen/chitosan/heparin complex with improved biocompatibility for hepatic tissue engineering. J Bioact Compat Polym 2005; 20: 15-28.
47. Cui K, Zhu Y, Wang X, et al. A porous scaffold from bone-like powder loaded in a collagen–chitosan matrix. J Bioact Compat Polym 2004; 19: 17-31.
48. Wang X, Yan Y, Zhang R, et al. Anastomosis of small arteries using a soluble stent and bioglue. J Bioact Compat Polym 2004; 19: 409-19.
49. Wang X, Yan Y, Xiong Z, et al. Preparation and evaluation of ammonia-treated collagen/chitosan matrices for liver tissue engineering. J Biomed Mater Res B Appl Biomater 2005; 75: 91-8.
50. Wang X, Yan Y, Lin F, et al. Preparation and characterization of a collagen/chitosan/heparin matrix for an implantable bioartificial liver. J Biomater Sci Polym Ed 2005; 16: 1063-80.
51. Wang X, Yu X, Yan Y, et al. Liver tissue responses to gelatin and gelatin/chitosan gels. J Biomed Mater Res A 2008; 87: 62-8.
52. Goldberg M, Langer R, Jia X. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed 2007;18:241-68.
53. Shim G, Park JY, Roh LD, et al. Applications of ligand-engineered nanomedicines. In: Yeo Y, editor. Nanoparticulate Drug Delivery Systems: Strategies, Technologies, and Applications. New Jersey: Wiley, 2013, p. 21-50.
54. Bajaj G, Yeo Y. Tumor-targeted nanoparticles: state-of-the-art and remaining challenges. In: Yeo Y, editor. Nanoparticulate Drug Delivery Systems: Strategies, Technologies, and Applications. New Jersey: Wiley, 2013, p. 1-20.
55. Zhang S, Uluda H. Nanoparticulate systems for growth factor delivery. Pharm Res 2009; 26: 1561-80.
56. Nguyen J, Szoka FC. Nucleic acid delivery: the missing pieces of the puzzle? Acc Chem Res 2012; 45: 1153-62.
57. Canal F, Sanchis J, Vicent MJ. Polymer--drug conjugates as nanosized medicines. Curr Opin Biotechnol 2011; 22: 894-900.
58. Yang Y, Yang Y, Xie X, et al. Preparation and characterization of photo-responsive cell-penetrating peptide-mediated nanostructured lipid carrier. J Drug Target 2014; 22: 891-900.
59. Nagarwal RC, Kumar R, Dhanawat M, et al. Nanocrystal technology in the delivery of poorly soluble drugs: an overview. Curr Drug Deliv 2011; 8: 398-406.
60. Knowles T, Oppenheim T, Buell A, et al. Nanostructured films from hierarchical self-assembly of amyloidogenic proteins. Nat Nanotechnol 2010; 5: 204-7.
61. Fubini B, Fenoglio I, Tomatis M, et al. Effect of chemical composition and state of the surface on the toxic response to high aspect ratio nanomaterials. Nanomedicine2011; 6: 899-920.
62. Langer R, Joseph P. Vacanti. Tissue engineering. Science 1993; 260: 920-6.
63. Vallet-Regí M. Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering. Chemistry 2006; 12: 5934-43.
64. Allen C, Yu Y, Maysinger D, et al. Polycaprolactonebpoly(ethylene oxide) block copolymer micelles as a novel drug delivery vehicle for neurotrophic agents FK506 and L-685,818. Bioconjug Chem 1998; 9:564-72.
65. Agrawal CM, Ray RB. Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. J Biomed Mater Res 2001; 55: 141-50.
66. Hämäläinen KM, Määttä E, Piirainen H, et al. Roles of acid/base nature and molecular weight in drug release from matrices of gelfoam and monoisopropyl ester of poly(vinyl methyl ether-maleic anhydride). J Control Release 1998; 56: 273-83.
67. Altunbas A, Pochan DJ. Peptide-based and polypeptide-based hydrogels for drug delivery and tissue engineering. Top Curr Chem 2012; 310: 135-67. In: Deming T, editor. Peptide-Based Materials. Berlin: Springer Heidelberg, 2012, p. 135-67.
68. Wang X. Overview on biocompatibilities of implantable biomaterials. In: Pignatello R, editor. Advances in Biomaterials Science and Biomedical Applications. Croatia: InTech; 2013, p. 111-55.
69. Widmaier EP, Raff H, Strang KT. Vander's human physiology: the mechanisms of body function. McGraw-Hill Higher Education, 2011.
70. Benková E, Michniewicz M, Sauer M, et al. Local, effluxdependent auxin gradients as a common module for plant organ formation. Cell 2003; 115: 591-602.
71. Murphy SV, Atala A. Organ engineering-combining stem cells, biomaterials, and bioreactors to produce bioengineered organs for transplantation. Bioessays 2013; 35: 163-72.
72. Macchiarini P, Jungebluth P, Go T, et al. Clinical transplantation of a tissue-engineered airway. Lancet 2008; 372: 2023-30.
73. Lumpkins SB, Pierre N, McFetridge PS. A mechanical evaluation of three decellularization methods in the design of a xenogeneic scaffold for tissue engineering the temporomandibular joint disc. Acta Biomater 2008; 4: 808-16.
74. Eberli D, Rodriguez S, Atala A, et al. In vivo evaluation of acellular human dermis for abdominal wall repair. J Biomed Mater Res A 2010; 93:1527-38.
75. Sabetkish S, Kajbafzadeh AM, Sabetkish N, et al. Whole-organ tissue engineering: decellularization and recellularization of threedimensional matrix liver scaffolds. J Biomed Mater Res A 2014. doi: 10.1002/jbm.a.35291. [Epub ahead of print]
76. Atala A, Kasper FK, Mikos AG. Engineering complex tissues. Sci Transl Med 2012; 4: 160rv12.
77. Chamberlain MD, West ME, Lam GC, et al. In vivo remodelling of vascularizing engineered tissues. Ann Biomed Eng 2014. doi: 10.1007/s10439-014-1146-x. [Epub ahead of print]
78. Wang X. Intelligent freeform manufacturing of complex organs. Artif Organs 2012; 36: 951-61.
79. Wang X. Spatial effects of stem cell engagement in 3D printing constructs. J Stem Cells Res Rev & Rep 2014; 1; 5-9.
80. Wang X. 3D printing of intelligent scaffold for tissue engineering and regenerative medicine. In: Khang G, editor. Handbook of Intelligent Scaffold for Tissue Engineering and Regenerative Medicine the Second Edition, 2014, in press.
81. Wang XH, Yan YN, Zhang RJ. Recent trends and chanllenges in complex organ manufacturing. Tissue Eng Part B. 2010;16:189-97.
82. Toh YC, Lim TC, Tai D, et al. A microfluidic 3D hepatocyte chip for drug toxicity testing. Lab Chip 2009; 9: 2026-35.
83. Mironov V, Boland T, Trusk T, et al. Organ printing: computeraided jet-based 3D tissue engineering. Trends Biotechnol 2003; 21: 157-61.
84. Kitson PJ, Rosnes MH, Sans V, et al. Configurable 3D-Printed millifluidic and microfluidic 'lab on a chip' reactionware devices. Lab Chip 2012; 12: 3267-71.
85. Wang X, Yan Y, Zhang R. Gelatin-Based hydrogels for controlled cell assembly. In: Ottenbrite RM, Park K, Okano T, editors. Biomedical Applications of Hydrogels Handbook. New York: Springer, 2010. p. 269-284.
86. Wang X, Zhang Q. Overview on "Chinese-Finnish workshop on biomanufacturing and evaluation techniques". Artif Organs 2011; 35: E191-3.
87. Bártolo PJ, Almeida HA, Rezende RA, et al. Advanced processes to fabricate scaffolds for tissue engineering. In: Bidanda B, Bártolo PJ, editors. Virtual Prototyping & Bio Manufacturing in Medical Applications. US: Springer, 2008, p. 149-170.
88. Douglas TS. Additive manufacturing: from implants to organs. S Afr Med J 2014; 104: 408-9.
89. Xu M, Yan Y, Liu H, et al. Control adipose-derived stromal cells differentiation into adipose and endothelial cells in a 3-D structure established by cell-assembly technique. J Bioact Compat Polym 2009; 24: 31-47.
90. Zhao X, Liu L, Wang J, et al. In vitro vascularization of a combined system based on a 3D printing technique. J Tissue Eng Regen Med 2014. doi: 10.1002/term.1863.
91. Kundu J, Shim JH, Jang J, et al. An additive manufacturing-based PCL-alginate-chondrocyte bioprinted scaffold for cartilage tissue engineering. J Tissue Eng Regen Med 2013. doi: 10.1002/term.1682. [Epub ahead of print]
92. Zhao X, Wang X. Preparation of an adipose-derived stem cell/fibrin-poly(d,l-lactic-co-glycolic acid) construct based on a rapid prototyping technique. J Bioact Compat Polm 2013; 28: 191-203.
93. Wang X, Yan Y, Zhang R. Rapid prototyping as a tool for manufacturing bioartificial livers. Trends Biotechnol 2007; 25: 505-13.
94. Wang X, He K, Zhang W. Optimizing the fabrication processes for manufacturing a hybrid hierarchical polyurethane-cell/hydrogel construct. J Bioact Compat Polym 2013; 28: 303-19.
95. Conway EM, Collen D, Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res 2001; 49: 507-21.
96. Pandya NM, Dhalla NS, Santani DD. Angiogenesis-a new target for future therapy. Vascul Pharmacol 2006; 44: 265-74.
97. Uygun BE, Soto-Gutierrez A, Yagi H, et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 2010; 16: 814-20.
98. Deng X, Cao Y, Yan H, et al. Enhanced liver functions of HepG2 cells in the alginate/xyloglucan scaffold. Biotechnol Lett 2015; 37:235-40.
99. Xu W, Wang X, Yan, Y, et al. Rapid prototyping of threedimensional cell/gelatin/fibrinogen constructs for medical regeneration. J Bioact Compat Polym 2007; 22: 363-77.
100. Wang X, Yan Y, Pan Y, et al. Generation of three-dimensional hepatocyte/gelatin structures with rapid prototyping system. Tissue Eng 2006; 12: 83-90.
101. Yan Y, Wang X, Pan Y, et al. Fabrication of viable tissueengineered constructs with 3D cell-assembly technique. Biomaterials 2005; 26: 5864-71.
102. Yan Y, Wang X, Xiong Z, et al. Direct construction of a threedimensional structure with cells and hydrogel. J Bioact Compat Polym 2005; 20: 259-69.
103. Xu M, Wang X, Yan Y, et al. A cell-assembly derived physiological 3D model of the metabolic syndrome, based on adipose-derived stromal cells and a gelatin/alginate/fibrinogen matrix. Biomaterials 2010; 31: 3868-77.
104. Zhang T, Yan, Y, Wang X, et al. Three-dimensional gelatin and gelatin/hyaluronan hydrogel structures for traumatic brain injury. J Bioact Compat Polym 2007; 22: 19-29.
105. Li S, Xiong Z, Wang X, et al. Direct fabrication of a hybrid cell/hydrogel construct by a double-nozzle assembling technology. J Bioact Compat Polym 2009; 24: 249-65.
106. Li S, Yan Y, Xiong Z, et al. Gradient hydrogel construct based on an improved cell assembling system. J Bioact Compat Polym 2009; 24: 84-99.
107. Yao R, Zhang R, Yan Y, et al. In vitro angiogenesis of 3D tissue engineered adipose tissue. J Bioact Compat Polym 2009: 24: 5-24.
108. Yao R, Zhang R, Wang X. Design and evaluation of a cell microencapsulating device for cell assembly technology. J Bioact Compat Polym 2009; 24: 48-62.
109. Xu W, Wang X, Yan Y, et al. Rapid prototyping of polyurethane for the creation of branched vascular systems. J Bioact Compat Polym 2008; 23: 103-14. (Featured by Nature China on May 3, 2008)
110. Xu W, Wang X, Yan Y, et al. A polyurethane-gelatin hybrid construct for the manufacturing of implantable bioartificial livers. J Bioact Compat Polym 2008; 23: 409-22.
111. Cui T, Yan Y, Zhang R, et al. Rapid prototyping of a double layer polyurethane-collagen conduit for peripheral nerve regeneration. Tissue Eng Part C 2009; 15: 1-9.
112. Cui T, Wang X, Yan Y, et al. Rapid prototyping a new polyurethane-collagen conduit and its Schwann cell compatibility. J Bioact Compat Polym 2009; 24: 5-17.
113. Wang X, Cui T, Yan Y, et al. Peroneal nerve regeneration along a new polyurethane-collagen guide conduit. J Bioac Compat Polym 2009; 24: 109-27.
114. Huang Y, He K, Wang X. Rapid Prototyping of a hybrid hierarchical polyurethane-cell/hydrogel onstruct for regenerative medicine. Mater Sci Eng C 2013; 33: 3220-9.
115. He K, Wang X. Rapid prototyping of tubular polyurethane and cell/hydrogel constructs. J Bioact Compat Polym 2011; 26: 363-74.
116. Melchels FPW, Domingos MAN, Klein TJ, et al. Additive manufacturing of tissues and organs. Prog Polym Sci 2012; 37: 1079-104.
117. Bae SE, Son JS, Park K, et al. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine. J Control Release 2009; 133: 37-43.
118. Sill TJ, von Recum HA. Electrospinning: applications in drug delivery and tissue engineering. Biomaterials 2008; 29: 1989-2006.
119. Yoo HS, Kim TG, Park TG. Surface-functionalized electrospunnanofibers for tissue engineering and drug delivery. Adv Drug Deliv Rev 2009; 61: 1033-42.
120. Murphy SV, Atala A. 3D bioprinting of tissues and organs. Nat Biotechnol 2014; 32: 773-85.
121. Meinel AJ, Germershaus O, Luhmann T, et al. Electrospun matrices for localized drug delivery: current technologies and selected biomedical applications. Eur J Pharm Biopharm 2012; 81: 1-13.
122. Kenawy ER, Abdel-Hay FI, El-Newehy MH, et al. Processing of polymer nanofibers through electrospinning as drug delivery systems. Mater Chem Phys 2009; 113: 296-302.
123. Zeng J, Xu X, Chen X, et al. Biodegradable electrospun fibers for drug delivery. J Control Release 2003; 92: 227-31.
124. Zheng XT, Yu L, Li P, et al. On-chip investigation of cell-drug interactions. Adv Drug Deliv Rev 2013; 65: 1556-74.
125. Place ES, Evans ND, Stevens MM. Complexity in biomaterials for tissue engineering. Nat Mater 2009; 8: 457-70.
126. Chua CK, Tan LP, An J. Advanced nanobiomaterials for tissue engineering and regenerative medicine. Nanomedicine 2013; 8: 501-3.
127. Morelli S, Piscioneri A. Cell-material interactions. In: de Bartolo L, Bader A, editors. Biomaterials for Stem Cell Therapy: State of Art and Vision for the Future. Florida: CRC press, 2013, p. 153-60.
128. Wang X, Sui S. Pulsatile culture of a poly(DL-lactic-co-glycolic acid) sandwiched cell/hydrogel construct fabricated using a stepby-step mold/extraction method. Artif Organs 2011; 35: 645-55.
129. Wang X, Mäkitie AA, Paloheimo K, et al. A tubular PLGAsandwiched cell/hydrogel fabrication technique based on a step-bystep mold/extraction process. Adv Polym Tech 2011; 30: 163-73.
130. Wang X, Mäkitie AA, Paloheimo K S, et al. Characterization of a PLGA sandwiched cell/fibrin tubular construct and induction of the adipose derived stem cells into smooth muscle cells. Mater Sci Eng C 2011; 31: 801-8.
131. Wang X, Sui S, Liu C. Optimizing the step-by-step forming processes for fabricating a poly (DL-lactic-co-glycolic acid)-sandwiched cell/hydrogel construct. J Appl Polym Sci 2011; 120: 1199-207.
132. Ge Q, Dunn CK, Qi HJ, et al. Active origami by 4D printing. Smart Mater Struct 2014; 23: 094007.
133. Hanein D, Horwitz AR. The structure of cell-matrix adhesions: the new frontier. Curr Opin Cell Biol 2012; 24: 134-40.
134. Lowell CA, Mayadas TN. Overview: studying integrins in vivo. Methods Mol Biol 2012; 757: 369-97.
135. Leckband DE, le Duc Q, Wang N, et al. Mechanotransduction at cadherin-mediated adhesions. Curr Opin Cell Biol 2011; 23: 523-30.
136. Mousa SA. Adhesion molecules: potential therapeutic and diagnostic implications. Methods Mol Biol 2010; 663: 261-76.
137. de Mel A, Seifalian AM, Birchall MA. Orchestrating cell/material interactions for tissue engineering of surgical implants. Macromol Biosci 2012; 12: 1010-21.
138. Rychly J, Nebe B. Interface biology of implants. Cell Adhes Migr 2009; 3: 390-4.
139. Lavenus S, Ricquier JC, Louarn G, et al. Cell interaction with nanopatterned surface of implants. Nanomedicine 2010; 5: 937-47.
140. Horning JL, Sahoo SK, Vijayaraghavalu S, et al. 3-D tumor model for in vitro evaluation of anticancer drugs. Mol Pharm 2008; 5: 849-62.
141. Wang F, Weaver VM, Petersen OW, et al. Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc Natl Acad Sci U S A 1998; 95: 14821-6.
142. Anders M, Hansen R, Ding RX, et al. Disruption of 3D tissue integrity facilitates adenovirus infection by deregulating the coxsackievirus and adenovirus receptor. Proc Natl Acad Sci U S A 2003; 100: 1943-8.
143. Beningo KA, Dembo M, Wang YL. Responses of fibroblasts to anchorage of dorsal extracellular matrix receptors. Proc Natl Acad Sci U S A 2004; 101: 18024-9.
144. Ng KW, Leong DT, Hutmacher DW. The challenge to measure cell proliferation in two and three dimensions. Tissue Eng 2005; 11: 182-91.
145. Rhodes NP, Srivastava JK, Smith RF, et al. Metabolic and histological analysis of mesenchymal stem cells grown in 3-D hyaluronan-based scaffolds. J Mater Sci Mater Med 2004; 15: 391-5.
146. da Rocha EL, Porto LM, Rambo CR. Nanotechnology meets 3D in vitro models: tissue engineered tumors and cancer therapies. Mater Sci Eng C Mater Biol Appl 2014; 34: 270-9.
147. Seliktar D. Designing cell-compatible hydrogels for biomedical applications. Science 2012; 336: 1124-8.
148. Szot CS, Buchanan CF, Freeman JW, et al. 3D in vitro bioengineered tumors based on collagen I hydrogels. Biomaterials 2011; 32: 7905-12.
149. Konishi M, Tabata Y, Kariya M, et al. In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel. J Control Release 2005; 103: 7-19.
150. Fischbach C, Kong HJ, Hsiong SX, et al. Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc Natl Acad Sci U S A 2009; 106: 399-404.
151. Chandler EM, Berglund CM, Lee JS, et al. Stiffness of photocrosslinked RGD-alginate gels regulates adipose progenitor cell behavior. Biotechnol Bioeng 2011; 108: 1683-92.
152. Verbridge SS, Chandler EM, Fischbach C. Tissue-engineered three-dimensional tumor models to study tumor angiogenesis. Tissue Eng Part A 2010; 16: 2147-52.
153. Barron JA, Wu P, Ladouceur HD, et al. Biological laser printing: a novel technique for creating heterogeneous 3-dimensional cell patterns. Biomed Microdevices 2004; 6: 139-47.
154. Orlando G, Baptista P, Birchall M, et al. Regenerative medicine as applied to solid organ transplantation: current status and future challenges. Transpl Int 2011; 24: 223-232.
155. Peltola SM, Melchels FP, Grijpma DW, et al. A review of rapid prototyping techniques for tissue engineering purposes. Ann Med 2008;40:268-80.
156. Pearce JM. Materials science. Building research equipment with free, open-source hardware. Science 2012; 337: 1303-4.
157. Goldberg AD, Allis CD, Bernstein E. Epigenetics: a landscape takes shape. Cell 2007; 128: 635-8.
158. Deng J, Shoemaker R, Xie B, et al. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat Biotechnol 2009; 27: 353-60.
159. Kim D, Kim CH, Moon JI, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009; 4: 472-6.